Enhancing Delivery of Gene Therapies in the CNS to Improve Patient Outcomes
Time: 11:30 am
day: Day 2- translation 1
Details:
• Case study examples of extensive studies to determine the optimal route of administration for CNS therapies, comparing intrathecal (IT) and intravenous (IV) delivery methods
• The focus is on maximizing therapeutic delivery to the brain and spinal cord while minimizing systemic exposure, crucial for both gene therapy applications and antisense therapies
